These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10436551)

  • 1. [Clinical contribution of the newer fluoroquinolones in acute bacterial exacerbation of chronic bronchitis].
    Niederman MS
    Medicina (B Aires); 1999; 59 Suppl 1():23-30. PubMed ID: 10436551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    DeAbate CA; Bettis R; Munk ZM; Fleming H; Munn NJ; Riffer E; Bagby B; Giguere G; Collins JJ
    Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute exacerbations of chronic bronchitis. Preventing treatment failures and early reinfection.
    Verghese A; Ismail HM
    Postgrad Med; 1994 Dec; 96(8):75-6, 79-82, 87-9. PubMed ID: 7991479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.
    Appelbaum PC; Gillespie SH; Burley CJ; Tillotson GS
    Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute exacerbations of chronic bronchitis: antibiotic therapy.
    Anzueto A
    Semin Respir Crit Care Med; 2000; 21(2):97-106. PubMed ID: 16088723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolones in respiratory infections.
    Klein NC
    Semin Respir Infect; 1991 Sep; 6(3):131-5. PubMed ID: 1754733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newer oral antimicrobials and newer etiologic agents of acute bronchitis and acute exacerbations of chronic bronchitis.
    Wallace RJ
    Semin Respir Infect; 1988 Mar; 3(1):49-54. PubMed ID: 3129770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levofloxacin and sparfloxacin: new quinolone antibiotics.
    Martin SJ; Meyer JM; Chuck SK; Jung R; Messick CR; Pendland SL
    Ann Pharmacother; 1998 Mar; 32(3):320-36. PubMed ID: 9533064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis: a Spanish physician and patient experience.
    Miravitlles M; Ros F; Cobos A; Kubin R; Tillotson G
    Int J Clin Pract; 2001 Sep; 55(7):437-41. PubMed ID: 11594251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotics in the treatment of acute exacerbations of chronic bronchitis.
    Dever LL; Shashikumar K; Johanson WG
    Expert Opin Investig Drugs; 2002 Jul; 11(7):911-25. PubMed ID: 12084002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin.
    Lipsky BA; Unowsky J; Zhang H; Townsend L; Talbot GH
    Clin Ther; 1999 Jun; 21(6):954-65. PubMed ID: 10440620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group.
    Anzueto A; Niederman MS; Tillotson GS
    Clin Ther; 1998; 20(5):885-900. PubMed ID: 9829441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program.
    Jones RN; Pfaller MA
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S16-23. PubMed ID: 10984323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical perspectives on new antimicrobials: focus on fluoroquinolones.
    Talan DA
    Clin Infect Dis; 2001 Mar; 32 Suppl 1():S64-71. PubMed ID: 11249831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections.
    Yoo BK; Triller DM; Yong CS; Lodise TP
    Ann Pharmacother; 2004; 38(7-8):1226-35. PubMed ID: 15187209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prulifloxacin: a new fluoroquinolone for the treatment of acute exacerbation of chronic bronchitis.
    Cazzola M; Salvatori E; Dionisio P; Allegra L
    Pulm Pharmacol Ther; 2006; 19 Suppl 1():30-7. PubMed ID: 16359895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepancy between antibiotics administered in acute exacerbations of chronic bronchitis and susceptibility of isolated pathogens in respiratory samples: multicentre study in the primary care setting.
    Querol-Ribelles JM; Molina J; Naberan K; Esteban E; Herreras A; Garcia-de-Lomas J
    Int J Antimicrob Agents; 2006 Nov; 28(5):472-6. PubMed ID: 17046209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily.
    Chodosh S; Lakshminarayan S; Swarz H; Breisch S
    Antimicrob Agents Chemother; 1998 Jan; 42(1):114-20. PubMed ID: 9449270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacin.
    Cantón R; Lode H; Graninger W; Milkovich G
    Int J Antimicrob Agents; 2006 Sep; 28 Suppl 2():S115-27. PubMed ID: 16904873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.